RAFAEL HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent
RAFAEL HOLDINGS, INC. (RFL) reported Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent of 50.00% for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsOther · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. effective income tax rate reconciliation, tax settlement, other, percent for the quarter ending 2025-10-31 was 50.00%.
- RAFAEL HOLDINGS, INC. effective income tax rate reconciliation, tax settlement, other, percent for fiscal 2025 was 50.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent 3 month | Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent 6 month | Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent 9 month | Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent 12 month |
|---|---|---|---|---|
| 2026-04-30 | 50.00% 10-Q · filed 2026-06-11 | |||
| 2026-01-31 | 50.00% 10-Q · filed 2026-03-16 | |||
| 2025-10-31 | 50.00% 10-Q · filed 2025-12-12 | |||
| 2025-07-31 | 50.00% 10-K · filed 2025-10-29 | |||
| 2025-04-30 | 50.00% 10-Q · filed 2025-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |